 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
Myriad RBM Collaborating with Sanofi on Protein Biomarkers for Diabetes Diagnosis, Drug Response
December 14, 2012
Myriad RBM Collaborating with Sanofi on Protein Biomarkers for Diabetes Diagnosis, Drug Response
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Caprion Leading $21M Clinical Biomarker and Personalized Medicine Development Project
February 22, 2013 / ProteoMonitor - KineMed, MedImmune Studying Role of Protein Dynamics in Neurodegenerative Diseases
May 21, 2013 / GenomeWeb Daily News - KineMed, Pfizer Renew Metabolic Disease Research Collaboration
March 27, 2013 / GenomeWeb Daily News - KineMed Inks Pact with Isis and CHDI for Protein Markers for Huntington's Disease
March 1, 2013 / ProteoMonitor - Multi-Center, Multi-Cohort Alzheimer's Study Identifies Four Potential Protein Markers
August 17, 2012 / ProteoMonitor